journal article·2021-05Open access

DNA‐Grafted Hyaluronic Acid System with Enhanced Injectability and Biostability for Photo‐Controlled Osteoarthritis Gene Therapy

Zhijie Chen, Feng Zhang, Hongbo Zhang, Liang Cheng, Kaizhe Chen, Jieliang Shen, Jin Qi, Lianfu Deng, Chuan He, Hélder A. Santos, Wenguo Cui

Advanced Science· Volume 8· Issue 9

Abstract

Abstract Gene therapy is identified as a powerful strategy to overcome the limitations of traditional therapeutics to achieve satisfactory effects. However, various challenges related to the dosage form, delivery method, and, especially, application value, hampered the clinical transition of gene therapy. Here, aiming to regulate the cartilage inflammation and degeneration related abnormal IL‐1β mRNA expression in osteoarthritis (OA), the interference oligonucleotides is integrated with the Au nanorods to fabricate the spherical nucleic acids (SNAs), to promote the stability and cell internalization efficiency. Furthermore, the complementary oligonucleotides are grafted onto hyaluronic acid (HA) to obtained DNA‐grafted HA (DNAHA) for SNAs delivery by base pairing, resulting in significantly improved injectability and bio‐stability of the system. After loading SNAs, the constructed DNAHA‐SNAs system (HA‐SNAs) performs a reversible NIR‐triggered on‐demand release of SNAs by photo‐thermal induced DNA dehybridization and followed by post‐NIR in situ hybridization. The in vitro and in vivo experiments showed that this system down‐regulated catabolic proteases and up‐regulated anabolic components in cartilage over extended periods of time, to safeguard the chondrocytes against degenerative changes and impede the continual advancement of OA.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Osteoarthritis Treatment and Mechanisms · RNA Interference and Gene Delivery · Silk-based biomaterials and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopaedics Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases Shanghai Institute of Traumatology and Orthopaedics Ruijin Hospital Shanghai Jiao Tong University School of Medicine 197 Ruijin 2nd Road Shanghai 200025 P. R. China

Drug Research Program Division of Pharmaceutical Chemistry and Technology Faculty of Pharmacy University of Helsinki Helsinki FI‐00014 Finland

Pharmaceutical Sciences Laboratory and Turku Bioscience Centre Åbo Akademi University Turku FI‐20520 Finland

Helsinki Institute of Life Science (HiLIFE) University of Helsinki Helsinki FI‐00014 Finland

Funding

National Natural Science Foundation of China · Shanghai Jiao Tong University · Shanghai Municipal Education Commission · Sigrid Juséliuksen Säätiö

References (42)

Show source-provided references
1. 10.1016/S0140-6736(19)30417-910.1016/S0140-6736(19)30417-9 ↗
2. 10.1136/annrheumdis-2018-21472410.1136/annrheumdis-2018-214724 ↗
3. 10.1038/nrrheum.2010.19610.1038/nrrheum.2010.196 ↗
4. 10.1016/S0140-6736(14)60802-310.1016/S0140-6736(14)60802-3 ↗
5. 10.1038/s41584-018-0123-410.1038/s41584-018-0123-4 ↗
6. 10.1002/art.4114210.1002/art.41142 ↗
7. 10.1038/nrrheum.2015.2810.1038/nrrheum.2015.28 ↗
8. 10.1016/j.jconrel.2017.03.00410.1016/j.jconrel.2017.03.004 ↗
9. 10.1016/j.jconrel.2018.12.03010.1016/j.jconrel.2018.12.030 ↗
10. 10.1089/hum.2015.07010.1089/hum.2015.070 ↗
11. 10.1038/nrd83710.1038/nrd837 ↗
12. 10.1186/ar467910.1186/ar4679 ↗
13. 10.1016/j.joca.2015.07.00810.1016/j.joca.2015.07.008 ↗
14. 10.3390/ijms16112594310.3390/ijms161125943 ↗
15. 10.1007/s40259-018-0290-510.1007/s40259-018-0290-5 ↗
16. 10.1007/978-3-319-16555-4_210.1007/978-3-319-16555-4_2 ↗
17. 10.1016/j.csm.2018.08.00610.1016/j.csm.2018.08.006 ↗
18. 10.1002/adma.20100396310.1002/adma.201003963 ↗
19. 10.1002/advs.20180085210.1002/advs.201800852 ↗
20. 10.1016/j.biomaterials.2019.11951610.1016/j.biomaterials.2019.119516 ↗
21. 10.1016/j.biomaterials.2019.11945110.1016/j.biomaterials.2019.119451 ↗
22. 10.1021/nn202070n10.1021/nn202070n ↗
23. 10.1021/acsnano.9b0108710.1021/acsnano.9b01087 ↗
24. 10.1021/acs.nanolett.8b0068910.1021/acs.nanolett.8b00689 ↗
25. 10.1002/adma.20180354910.1002/adma.201803549 ↗
26. 10.1021/acsami.8b0712010.1021/acsami.8b07120 ↗
27. 10.1016/j.biomaterials.2019.11947310.1016/j.biomaterials.2019.119473 ↗
28. 10.1016/j.biomaterials.2013.09.03410.1016/j.biomaterials.2013.09.034 ↗
29. 10.3390/pharmaceutics1108040710.3390/pharmaceutics11080407 ↗
30. 10.1038/nrrheum.2014.15710.1038/nrrheum.2014.157 ↗
31. 10.2217/nnm-2016-007010.2217/nnm-2016-0070 ↗
32. 10.1208/aapsj07010910.1208/aapsj070109 ↗
33. 10.12688/f1000research.6885.110.12688/f1000research.6885.1 ↗
34. 10.1016/j.carbpol.2017.04.02810.1016/j.carbpol.2017.04.028 ↗
35. 10.1016/j.carbpol.2018.01.05610.1016/j.carbpol.2018.01.056 ↗
36. 10.1016/j.jconrel.2019.04.00310.1016/j.jconrel.2019.04.003 ↗
37. 10.1016/j.ijbiomac.2018.10.04910.1016/j.ijbiomac.2018.10.049 ↗
38. 10.1038/nrdp.2016.7210.1038/nrdp.2016.72 ↗
39. 10.1002/adfm.20180755910.1002/adfm.201807559 ↗
40. 10.1016/j.joca.2007.03.00610.1016/j.joca.2007.03.006 ↗
41. 10.1038/nprot.2008.9510.1038/nprot.2008.95 ↗
42. 10.1016/j.joca.2005.07.01410.1016/j.joca.2005.07.014 ↗